Tuesday, May 5, 2009
MIT Targeting Tumors Using Gold Nanorods
The researchers at MIT are at it again. This time, they're using gold nanorods to target malignant tumors. It's great to see so much research in nanotechnology. The team includes an MIT graduate student named Geoffrey von Maltzahn (who won the Lemelson-MIT Student Prize, in part for his work with the nanorods). von Maltzahn developed the tumor-homing particles with Sangeeta Bhatia, MD, PhD, professor in the Harvard-MIT Division of Health Sciences and Technology (HST) and in the Department of Electrical Engineering and Computer Science, a member of the David H. Koch Institute for Integrative Cancer Research at MIT and a Howard Hughes Medical Institute Investigator.
Doctor Sangeeta Bhatia and I actually have a few things in common: we both studied mechanical engineering at MIT (I did my undergrad while she got her master's), we were both in Boston in the late nineties, and we both went to medical school (but different medical schools). Now, she holds 12 issued or pending patents and has worked in industry at Pfizer, Genetics Institute, ICI Pharmaceuticals, and Organogenesis.